Financial statements Noblepharma
Balance sheet of Noblepharma
Company age:
Age:
15 y. 3 m. 7 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of NOBLEPHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Total assets | 895 488,73 | 1 058 771,57 | 1 390 551,94 | 1 881 877,99 |
| A. Fixed assets | - | - | - | - |
| B. Current assets | 895 488,73 | 1 058 771,57 | 1 390 551,94 | 1 881 877,99 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 895 488,73 | 1 058 771,57 | 1 390 551,94 | 1 881 877,99 |
| A. Equity | 157 946,07 | 255 904,61 | 281 175,35 | 246 492,34 |
| B. Liabilities and provisions for liabilities | 737 542,66 | 802 866,96 | 1 109 376,59 | 1 635 385,65 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.